UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Glycolysis as a therapeutic target for Parkinson's disease

Foltynie, T; (2019) Glycolysis as a therapeutic target for Parkinson's disease. Lancet Neurology , 18 (12) pp. 1072-1074. 10.1016/S1474-4422(19)30404-1. Green open access

[thumbnail of Foltynie Terazocin is used as a treatment for prostatism in view of its known alpha 1 antagonist effects.pdf]
Preview
 Text
Foltynie Terazocin is used as a treatment for prostatism in view of its known alpha 1 antagonist effects.pdf - Accepted Version
Download (363kB) | Preview
Type: Article
Title: Glycolysis as a therapeutic target for Parkinson's disease
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S1474-4422(19)30404-1
Publisher version: https://doi.org/10.1016/S1474-4422(19)30404-1
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10085843
Downloads since deposit
1,376Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item